Executive Summary
The July 10, 2026, filing batch reveals a pronounced wave of negative corporate actions, with a cluster of delistings (7 filings) and insolvency updates (5 filings) dominating the high-priority event landscape.
A significant trend is the surge in SPAC activity, including a major valuation reduction in a pending merger (Plum Acquisition Corp IV cutting its target valuation by 30% to $3.15B) and multiple SPACs extending deadlines or completing IPOs, signaling both opportunity and distress in the blank-check sector. The healthcare and life sciences sector is a focal point for M&A, with GSK's $124/share tender offer for Nuvalent clearing its HSR waiting period and a $500M pre-money SPAC merger for HCC Healthcare. Financial distress is evident across several small-cap companies, with 4 Nasdaq non-compliance/delisting notices and a major fraud declaration by IREDA against Gensol Engineering for ₹672.74 Crore. From a period-over-period perspective, Rotographics' target Teneron showed an 11.3% YoY revenue decline, while Brandywine's office disposition removed $4.7M in quarterly revenue, highlighting asset-level pressure in commercial real estate. Insider activity is limited in this batch, but capital allocation patterns show a mix of strategic M&A, debt financing for acquisitions, and balance sheet restructuring through share cancellations and stock splits.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from July 09, 2026.
Investment Signals (10)
- GSK / Nuvalent (BULLISH)▲
HSR waiting period expired on July 9, clearing a key regulatory hurdle for the $124/share cash tender offer. This removes a major deal risk and signals high probability of closure, with the offer now subject only to remaining customary conditions.
- Kuva Labs / Lisata Therapeutics ↓ (BULLISH)▲
Tender offer extended to July 16 with 55.98% of shares already tendered, suggesting strong shareholder acceptance. The $4.00/share cash plus CVR structure (up to $3.00 additional) provides a floor with upside optionality.
- Rotographics (India) ↓ (MIXED)▲
Board approved acquisition of up to 51% of Teneron (FY25 revenue ₹7080 Cr) and a 1:5 stock split to enhance liquidity. However, Teneron's revenue declined 11.3% YoY (from ₹798 Cr to ₹708 Cr), creating execution risk. The mixed signal warrants caution.
- Mercer International ↓ (BEARISH)▲
Received Nasdaq bid price deficiency notice but has a 180-day compliance period. The stock is trading near $1.00, and the company is actively monitoring, suggesting potential for a reverse split or operational catalyst to regain compliance.
- Brandywine Realty Trust (MIXED)▲
Completed $151M disposition of an Austin office asset, generating $146.1M net proceeds. The pro forma shows a $38M gain in FY2025 but a $1.7M increase in Q1 2026 net loss due to lost operating income, indicating the asset was cash-flow positive but the sale strengthens the balance sheet.
- Plum Acquisition Corp IV ↓ (BEARISH)▲
Amended merger terms with Controlled Thermal Resources, cutting valuation from $4.5B to $3.15B (30% reduction) and extending the outside closing date to April 2027. While this improves deal feasibility, the massive valuation cut signals significant seller capitulation and potential underlying asset issues.
- Viking Acquisition Corp II ↓ (BULLISH)▲
Completed $230M IPO (23M units at $10.00) with full exercise of over-allotment, signaling strong institutional demand for this blank-check vehicle. The sponsor's $6.1M private placement aligns incentives.
- Meridian3 Industrials Acquisition Corp ↓ (BULLISH)▲
Completed $201.25M IPO with $5.5M private placement. The SPAC is well-capitalized for a future business combination, and the warrant structure ($11.50 strike) provides upside leverage for investors.
- Aditya Birla Fashion and Retail ↓ (BULLISH)▲
NCLT approved scheme of amalgamation with Jaypore E-Commerce and TG Apparel, effective August 1, 2026. This consolidation should create operational synergies and streamline the e-commerce and apparel verticals.
- JSW Infrastructure ↓ (BULLISH)▲
Incorporated a new subsidiary for a PPP port project in Kolkata under a DBFOT model. This expands the company's port infrastructure footprint and aligns with India's infrastructure push, though initial capital is minimal (₹1,00,000).
Risk Flags (10)
- GoHealth / Delisting↓ [HIGH RISK]▼
Final Nasdaq delisting effective July 20, 2026, after the company did not appeal the determination. This is a terminal event for public equity holders, with trading already suspended since June 16.
- Inotiv / Delisting↓ [HIGH RISK]▼
Delisting from Nasdaq effective July 20, 2026, after failing to meet listing requirements and not appealing. The stock was suspended on June 11, leaving shareholders with no public market.
- Reviva Pharmaceuticals / Delisting↓ [HIGH RISK]▼
Final delisting from Nasdaq effective July 20, 2026, after failing to meet bid price requirements despite multiple appeals and extensions. The stock has been suspended since May 14.
- IREDA / Fraud Investigation [HIGH RISK]▼
Declared Gensol Engineering and its subsidiary as fraud accounts with ₹672.74 Crore outstanding (85% provisioned). The fraud involves misappropriation and forgery, posing reputational and recovery risk for IREDA and signaling potential contagion in the renewable energy lending space.
- GeoVax Labs / Nasdaq Non-Compliance↓ [HIGH RISK]▼
Received notice for failing to meet the $2.5M minimum stockholders' equity requirement. Has 45 days to submit a compliance plan; failure could lead to delisting. The company also failed alternative compliance measures.
- NanoVibronix / Delisting Risk↓ [HIGH RISK]▼
Received Nasdaq Staff Determination for bid price below $1.00 for 30 consecutive days. Ineligible for standard 180-day cure period due to prior reverse split. The company will appeal, but delisting risk is elevated.
- T1 Energy (FREYR Battery) / Delisting [HIGH RISK]▼
Warrants being delisted from NYSE effective July 21, 2026, after suspension on July 9. The warrants now represent only the right to receive immediate cash, eliminating equity conversion optionality.
- ▼
Final delisting from Nasdaq effective July 20, 2026, after failing to qualify under Rule IM-5101-2. The company did not appeal, and securities were suspended since May 14.
- Skillsoft Corp / Financial Losses↓ [HIGH RISK]▼
Continuing operations generated a net loss of $18.5M in Q1 2026 and $84.4M in FY2025. The sale of Global Knowledge for up to $15.4M provides some liquidity but the core business remains unprofitable.
- Spring Valley Acquisition Corp III / Delisting↓ [HIGH RISK]▼
Delisted from Nasdaq effective July 10, 2026, under SEC Rule 12d2-2(a)(3). The SPAC failed to complete a business combination or maintain listing standards.
Opportunities (9)
- GSK / Nuvalent (OPPORTUNITY)◆
With the HSR waiting period expired, the $124/share tender offer is on track. Arbitrageurs can capture the spread between current trading price and offer price, with deal risk significantly reduced. The expiration of the HSR period is a major milestone.
- Kuva Labs / Lisata Therapeutics↓ (OPPORTUNITY)◆
With 55.98% of shares tendered and the offer extended to July 16, the deal is likely to close. The $4.00/share cash plus CVR (up to $3.00) provides a base return with potential upside from milestones. The extension suggests the minimum tender condition is close to being met.
- Rotographics (India) / Turnaround Play↓ (OPPORTUNITY)◆
The proposed acquisition of Teneron (51% stake) and 1:5 stock split could unlock value. Despite Teneron's 11.3% revenue decline, the non-ferrous metal recycling sector has cyclical upside. The stock split should improve liquidity and attract retail investors.
- Brandywine Realty Trust / Balance Sheet Improvement (OPPORTUNITY)◆
The $151M office sale in Austin strengthens the balance sheet with $146.1M in cash proceeds. The company is deleveraging in a challenged office market, and the pro forma gain of $38M in FY2025 improves book value.
- Viking Acquisition Corp II / SPAC IPO↓ (OPPORTUNITY)◆
A fresh $230M SPAC with strong institutional backing and full over-allotment exercise. Investors can participate in the trust value ($10/unit) with downside protection and upside optionality from a future business combination.
- Meridian3 Industrials Acquisition Corp / SPAC IPO↓ (OPPORTUNITY)◆
A $201.25M SPAC focused on industrials, with warrants exercisable at $11.50. The industrial sector focus aligns with reshoring and infrastructure trends. The trust provides a floor at $10/unit.
- JSW Infrastructure / PPP Port Project↓ (OPPORTUNITY)◆
The new subsidiary for the Kolkata outer container terminal under a DBFOT model positions JSW to benefit from India's port modernization. The PPP structure provides long-term, inflation-linked revenue streams.
- Ugro Capital / Amalgamation with Profectus↓ (OPPORTUNITY)◆
Received NSE/BSE no-objection for the scheme of amalgamation with Profectus Capital. The merger should create a larger NBFC with scale benefits, though regulatory conditions require monitoring.
- Kitex Garments / Demerger Consolidation↓ (OPPORTUNITY)◆
The scheme to demerge Kitex Childrenswear's textile division into KGL aims to create operational efficiencies. With both entities employing ~4,900 people each, the consolidation could unlock significant synergies.
Sector Themes (6)
- SPAC Market Reset◆
Multiple SPAC filings reveal a market in transition. Plum Acquisition Corp IV cut its merger valuation by 30% ($4.5B to $3.15B), while Quetta Acquisition Corp extended its deadline by one month, signaling deal-making challenges. Conversely, two new SPAC IPOs (Viking Acquisition Corp II at $230M and Meridian3 Industrials Acquisition Corp at $201.25M) show continued capital formation. The theme is bifurcation: well-capitalized SPACs with strong sponsors are launching, while existing SPACs struggle with valuation and deadlines.
- Delisting Wave in Small-Cap Biotech/Tech◆
Seven delisting notices were filed, concentrated in small-cap healthcare (Reviva Pharmaceuticals, NanoVibronix), technology (GoHealth, Inotiv), and SPACs (Spring Valley, Alchemy Investments). This reflects a tightening of Nasdaq listing standards and the inability of micro-cap companies to maintain compliance post-market downturn. The pattern suggests a cleansing of the small-cap ecosystem but creates significant losses for retail holders.
- Healthcare M&A Acceleration◆
The healthcare sector saw significant M&A activity. GSK's $124/share tender for Nuvalent cleared HSR, HCC Healthcare's $500M SPAC merger with RF Acquisition Corp III is on track for Q4 2026, and Inventurus Knowledge Solutions is progressing on its TruBridge acquisition with a $635M financing facility. This indicates robust deal-making in pharma and healthcare services, driven by strategic consolidation and access to capital.
- Indian Corporate Restructuring and Insolvency◆
Multiple Indian filings show active corporate restructuring. SAB Events & Governance Now Media received NCLT approval for its resolution plan (positive), while JBF Industries and Vas Infrastructure remain in extended CIRP. The IREDA fraud declaration against Gensol Engineering for ₹672.74 Crore highlights credit risk in the renewable energy lending space. The theme is a two-track system: successful resolutions for some, prolonged distress for others.
- Commercial Real Estate Pressure◆
Brandywine Realty Trust's $151M office disposition in Austin, while strengthening the balance sheet, removed $4.7M in quarterly revenue and $1.7M in net income, illustrating the ongoing pressure on office assets. The pro forma shows that even cash-flow-positive properties are being sold to deleverage, reflecting a structural shift in office demand.
- Capital Allocation Divergence◆
Companies are taking divergent capital allocation approaches. Rotographics is pursuing aggressive M&A (51% of Teneron) and a stock split, while GAIL is reducing subsidiary share capital to simplify its structure. Lincoln Educational Services is taking on $15M in debt for property acquisition, while Brandywine is selling assets to generate cash. This divergence reflects varying confidence levels and strategic priorities across sectors.
Watch List (8)
-
Must submit a plan by August 21, 2026, to regain compliance with the $2.5M stockholders' equity requirement. Watch for the plan's acceptance and any equity raises or reverse splits.
-
The company is appealing the delisting determination. The hearing outcome will determine if the stock continues trading on Nasdaq or moves to OTC. Watch for the hearing date and Panel decision.
-
The amended merger with Controlled Thermal Resources has a new antitrust filing deadline of September 30, 2026, and an outside closing date of April 30, 2027. Watch for regulatory approvals and any further valuation adjustments.
-
The offer expires July 16, 2026. Watch for the final tender results and whether the minimum condition is met. The $25M convertible note financing is also a key factor.
- GSK / Nuvalent Tender Offer👁
With HSR cleared, watch for the expiration of the tender offer and any competing bids. The $124/share offer represents a significant premium, and the deal is now in its final stages.
- IREDA / Gensol Engineering Fraud Case👁
Watch for RBI's response and any further disclosures on recovery proceedings. The ₹672.74 Crore exposure (85% provisioned) could lead to credit rating actions or regulatory scrutiny on IREDA's underwriting standards.
-
The proposed acquisition of Teneron, stock split, and name change require shareholder and regulatory approvals. Watch for the shareholder meeting date and any opposition from minority investors.
-
The scheme of amalgamation with Profectus Capital must be submitted to NCLT within six months (by January 9, 2027). Watch for shareholder and creditor meeting outcomes and any regulatory objections.
Filing Analyses
(48)
10-07-2026
Grameva Limited (formerly Bangalore Fort Farms Limited) announced the successful completion of an Open Offer by Acquirers Mrs. Maneesha Singh, Jagsakti Merchandise Private Limited, and Ros Advisory Private Limited, who have acquired substantial shareholding and control of the company effective July 10, 2026. The existing promoter, Genesis Trade-Links Private Limited, ceases to exercise control and will be re-classified. The board meeting took place from 11:00 AM to 11:30 AM on the same date.
- · The Open Offer was made under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
- · The Acquirers have been classified as the Promoter/Promoter Group effective July 10, 2026.
- · The existing promoter Genesis Trade-Links Private Limited will be re-classified subject to regulatory filings.
10-07-2026
Bangalore Fort Farms Limited (now Grameva Limited) has completed an Open Offer by acquirers Mrs. Maneesha Singh, Jagsakti Merchandise Private Limited, and Ros Advisory Private Limited. As a result, promoter Genesis Trade-Links Private Limited has been reclassified from 'Promoter' to 'Public' category after selling its entire 33.25% stake (15,95,693 shares) to nil. The acquirers are now classified as the new Promoters/Promoter Group of the company.
- · The Open Offer was completed on Thursday, April 16, 2026.
- · The Letter of Offer was dated March 16, 2026.
- · The promoter's intent letter for reclassification was dated February 04, 2026.
- · The reclassified entity (Genesis Trade-Links) confirms it does not hold more than 10% voting rights, does not exercise control, has no special rights, and will not be on the Board or act as KMP for three years.
- · The company confirms compliance with minimum public shareholding requirements, shares are not suspended from trading on BSE and Calcutta Stock Exchange, and no outstanding dues to SEBI, stock exchanges, or depositories.
- · The company's name changed from Bangalore Fort Farms Limited to Grameva Limited.
10-07-2026
Gujarat Fluorochemicals Limited (GFCL) has received No Objection Letters (NOLs) from BSE and NSE on July 9, 2026, for its Composite Scheme of Arrangement involving Inox Leasing and Finance Limited (ILFL, the demerged company), Inox Holdings and Investments Limited (IHIL, the resulting company), and GFCL (the transferee company). The NOLs are subject to numerous compliance conditions, including detailed disclosures to shareholders, surrender of ILFL's NBFC license, and filing with NCLT within six months. The scheme aims to restructure the group entities, but the filing does not provide any financial performance data for GFCL or the other entities involved.
- · The NOLs from BSE and NSE were received on July 9, 2026, and disclosed on July 10, 2026.
- · The scheme involves the demerger of ILFL (the holding company of GFCL) into IHIL, with GFCL as the transferee company.
- · SEBI's comments require that ILFL surrender its NBFC Certificate of Registration to RBI within 15 days of the Effective Date of the Scheme.
- · The NOL is valid for six months from July 9, 2026, within which the scheme must be submitted to NCLT.
- · The scheme requires compliance with Regulation 11 of SEBI LODR (maintaining minimum public shareholding) and other conditions.
- · Shareholders must receive detailed disclosures including valuation reports, share exchange ratio rationale, pre- and post-scheme shareholding, and financials of all entities involved.
- · The scheme includes the transfer of mutual fund distribution activities and brokerage income from ILFL to IHIL.
10-07-2026
Aurobindo Pharma Limited disclosed that its wholly owned step-down subsidiary, PT Aurogen Pharma Indonesia, incorporated a new wholly owned subsidiary, PT Auro Pharm Indonesia, in Indonesia on July 1, 2026, with incorporation approval received on July 9, 2026. The new entity, capitalized with an initial share capital of IDR 20,000,000,000 (2000 equity shares of IDR 10,000,000 each), will undertake manufacturing operations in the pharmaceuticals industry. The transaction is a related-party transaction as the new subsidiary is a step-down subsidiary of the company, but the promoters/promoter group have no interest in it.
- · The new subsidiary PT Auro Pharm Indonesia was incorporated on July 1, 2026, and approval from authorities was received on July 9, 2026.
- · The initial share capital is IDR 20,000,000,000 divided into 2000 equity shares of IDR 10,000,000 each.
- · The acquisition is a related-party transaction as the new entity is a wholly owned step-down subsidiary of Aurobindo Pharma Limited.
- · No governmental or regulatory approvals were required for the acquisition.
- · The consideration is 100% cash subscription to the share capital.
10-07-2026
The Hon'ble SAT has set aside SEBI's earlier directions (dated 30.01.2026 and 27.10.2025) in the matter of the open offer by Marwadi Chandarana Intermediaries Brokers Private Limited to shareholders of TruCap Finance Limited, and remanded the matter back to SEBI for a speaking order. This is a procedural update; no financial figures or quantitative data are disclosed in the filing.
- · The appeal was heard on July 08, 2026.
- · The SAT set aside SEBI's communication dated 30.01.2026 and prior communication dated 27.10.2025.
- · The matter has been remanded to SEBI for passing a speaking order.
- · This filing is an update to a previous submission made on June 29, 2026.
10-07-2026
Eureka Acquisition Corp (EURKU) issued a $8,253.03 promissory note to Marine Thinking Inc. on July 7, 2026, to fund working capital in connection with a potential business combination. The note is non-interest bearing, convertible into units at $10.00 per unit upon a business combination, and is repayable only from funds outside the trust account if no deal closes. This small loan signals ongoing efforts to consummate a merger, but the amount is minimal relative to typical SPAC trust sizes.
- · The note is non-interest bearing, with default interest at the prevailing short-term U.S. Treasury Bill rate.
- · Conversion right allows Marine Thinking Inc. to convert the note into units at $10.00 per unit, with no fractional units issued.
- · The note is repayable only from funds outside the trust account if no business combination occurs.
- · The note matures upon the earlier of a business combination or the expiry of the company's term.
- · The filing references the company's prospectus (File No. 333-277780).
10-07-2026
RF Acquisition Corp III (RFAM) has signed a Business Combination Agreement with HCC Healthcare Pte. Ltd., a Singapore-based integrated medical and long-term care services provider operating in Taiwan. The transaction values HCC Healthcare at approximately $500 million pre-money and is expected to close in Q4 2026, subject to shareholder approval, SEC effectiveness of the Form F-4, and other conditions. Post-closing, HCC Healthcare will list on Nasdaq, aiming to use the proceeds to accelerate consolidation and expansion of its care network; however, the deal carries standard risks including failure to obtain approvals, shareholder redemptions, and execution risks related to integrating affiliated providers and deploying AI technology.
- · The BCA reflects a pre-transaction equity value of HCC Healthcare of approximately US$500 million.
- · Transaction expected to close in Q4 2026, subject to shareholder approval, SEC effectiveness of Form F-4, and customary closing conditions.
- · Pro forma combined network encompasses more than 120 long-term care facilities and over 9,000 beds, including one institution with more than 1,300 beds.
- · Group provides case management for more than 7,000 individuals, with operations concentrated in Northern Taiwan (approximately one-third of Taiwan's population).
- · Strategic growth roadmap includes four priorities: AI platform, Japan market entry, wellness partnerships, and precision/regenerative medicine.
- · Certain operational information is presented on a combined or pro forma basis and includes affiliated and allied providers not wholly owned or consolidated.
- · No amounts or percentages are provided for historical financial performance or period-over-period comparisons.
10-07-2026
Constellation Acquisition Corp I (CSTWF) filed an 8-K on July 10, 2026, disclosing that Water Tower Research will host a virtual conversation on July 16, 2026, with HiTech Minerals CEO Ian Rodger to discuss the proposed business combination among CSTA, HiTech, and US Elemental Inc. (PubCo), and the anticipated Nasdaq listing of PubCo. The filing includes forward-looking statements about the McDermitt Lithium Project and cautions that no definitive financial metrics (e.g., NPV, IRR, production targets) are provided in this disclosure.
- · The virtual conversation is scheduled for July 16, 2026, at 14:00 pm ET.
- · The filing is furnished under Item 7.01 (Regulation FD Disclosure) and is not deemed filed for Exchange Act purposes.
- · The business combination involves three entities: CSTA (SPAC), HiTech Minerals, and US Elemental Inc. (PubCo).
- · PubCo intends to list on Nasdaq after the combination.
- · The filing contains extensive forward-looking statements and risk factors, but no specific financial figures or redemption data are disclosed.
10-07-2026
SJ Corporation Ltd has made an open offer under SEBI (SAST) Regulations, 2011, to acquire up to 1,12,72,300 shares (26.00% of expanded voting capital) at ₹12.00 per share in cash. The acquirers include Mr. Pintu Kanjibhai Kalavadia (Acquirer 1), Mr. Prashant Kanjibhai Kalavadia (Acquirer 2), Mr. Umang Kantilal Savani (Acquirer 3), and Mr. Kalpesh Patel (Acquirer 4), who had previously been allotted 2,17,00,000 equity shares representing 50.05% of the expanded voting share capital via a preferential issue. The offer follows a share subscription agreement and receipt of in-principle approval from BSE Limited.
- · The acquirers were allotted 2,17,00,000 equity shares (50.05% of expanded voting capital) with an aggregate consideration of ₹26,04,00,000.00 via a preferential issue, subject to escrow conditions.
- · On March 13, 2026, the Board of SJ Corporation allotted 3,50,00,000 equity shares at ₹12.00 each through a preferential issue.
- · The proceeds from the preferential issue were used to acquire 43,49,994 equity shares (99.99% on fully diluted basis) of Fishfa Rubbers Ltd, making it a wholly owned subsidiary.
- · The Independent Directors Committee (IDC) comprising Mr. Maulik Pravinbhai Dalsaniya (Chairperson), Mrs. Ekta Ankur Dholakia, and Mr. Pragnesh Kishorebhai Sonchhatra made recommendations on the offer on July 8, 2026.
- · The Public Announcement was initially made on January 30, 2026, and a corrigendum was published on May 8, 2026.
10-07-2026
JSW Infrastructure Limited has incorporated a wholly owned subsidiary, JSW Kolkata Outer Harbour Container Terminal Private Limited, on July 10, 2026. The subsidiary was established to fulfill the requirements of a Letter of Award (LOA) from Syama Prasad Mookerjee Port Authority, Kolkata, for the integrated development of an outer container terminal and berths on a Design Build Finance Operate Transfer (DBFOT) basis under a PPP model. The initial subscription cost is ₹1,00,000 for 10,000 equity shares, with JSWIL holding 100% ownership.
- · The subsidiary was incorporated in India on July 10, 2026, and is a wholly owned subsidiary of JSW Infrastructure Limited.
- · The LOA is for a PPP project on a Design Build Finance Operate Transfer (DBFOT) basis.
- · The subsidiary is classified under the infrastructure (port related) industry.
- · No governmental or regulatory approvals were required for the incorporation.
10-07-2026
MM Forgings Limited announced that the NCLT has approved the consolidation of the authorized share capital of D V S Industries Private Limited with its own, increasing its authorized share capital to ₹63,50,00,000 divided into 6,35,00,000 equity shares of ₹10 each. The amendment to the Memorandum of Association has been filed and is subject to MCA approval of Form INC-28. This is a procedural step following the scheme of amalgamation, with no financial impact or performance metrics disclosed.
- · The authorized share capital increased to ₹63,50,00,000 divided into 6,35,00,000 equity shares of ₹10 each.
- · Clause V of the Memorandum of Association has been amended accordingly.
- · The amended MOA is available on the company's website.
- · The share capital update is subject to MCA approval of Form INC-28.
10-07-2026
The Hon'ble National Company Law Tribunal (NCLT), Mumbai Bench, has orally approved the Resolution Plan for SAB Events & Governance Now Media Limited under the Pre-Packaged Insolvency Resolution Process (PPIRP). The detailed written order is awaited, and the company will make further disclosures upon receipt.
- · The resolution plan was approved under Section 54L of the Insolvency and Bankruptcy Code, 2016, read with the IBBI (Pre-Packaged Insolvency Resolution Process) Regulations, 2021.
- · The company had previously made disclosures regarding the PPIRP, indicating ongoing proceedings.
- · The certified copy of the NCLT order is awaited and will be submitted to stock exchanges upon receipt.
10-07-2026
JBF Industries Ltd has received NCLT approval to extend its Corporate Insolvency Resolution Process (CIRP) period. The Committee of Creditors decided to republish Form G and invite fresh Expressions of Interest from potential resolution applicants. The company remains under insolvency proceedings with no resolution plan finalized yet.
- · The NCLT Ahmedabad Bench permitted the extension of the CIRP period.
- · Form G was republished on July 10, 2026, inviting fresh Expressions of Interest.
- · The Resolution Professional is Mr. Mukesh Verma (IBBI Registration No: IBBI/IPA-001/IP-P01665/2019-2020/12522).
- · The company's registered office is in Silvassa, Dadra & Nagar Haveli.
10-07-2026
Vas Infrastructure Ltd. held its 26th Committee of Creditors meeting on July 9, 2026, under the Corporate Insolvency Resolution Process (CIRP). The outcome of the meeting was disclosed to BSE Limited on July 10, 2026, as required under SEBI LODR regulations. No specific financial figures or resolution details were provided in the filing.
- · The 26th meeting of the Committee of Creditors was held on July 9, 2026.
- · The company is under CIRP (Corporate Insolvency Resolution Process).
- · The Resolution Professional is Ashok Kumar Golechha, IBBI Reg. No. IBBI/IPA-002/IP-N000932/2019-20/12973.
- · No details of the meeting outcome (e.g., voting results, resolution plan status) were disclosed.
10-07-2026
Aditya Birla Fashion and Retail Limited (ABFRL) has received the certified order from the NCLT Mumbai Bench sanctioning the Scheme of Amalgamation among Jaypore E-Commerce Private Limited, TG Apparel & Decor Private Limited, and ABFRL. All conditions precedent have been satisfied, with the Effective Date set as August 1, 2026, and the Appointed Date as April 1, 2026. This is a routine procedural update regarding a court-approved merger, not an insolvency proceeding.
- · Certified copy of NCLT order filed with Registrar of Companies, Mumbai on July 10, 2026.
- · Effective Date of the Scheme: August 1, 2026.
- · Appointed Date as per the Scheme: April 1, 2026.
- · Earlier intimation dates referenced: February 5, 2026 and July 2, 2026.
10-07-2026
GAIL (India) Limited has completed the reduction of share capital of its subsidiary Konkan LNG Limited (KLL) following an NCLT order dated June 3, 2026. As a result, 14,81,10,440 equity shares of ₹10 each in KLL were cancelled, including 7,40,55,220 shares held by GAIL and an equal number held by MSEB Holding Company Limited. Post-cancellation, MSEB's holding in KLL has been reduced to nil, and GAIL's shareholding has increased to 100% of KLL's equity share capital.
- · The NCLT order approving the scheme was dated June 3, 2026.
- · Consideration for the share cancellation was remitted to GAIL and MSEB on July 6, 2026.
- · The disclosure is made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
10-07-2026
Winsome Yarns Limited informed exchanges that Mr. Manish Bagrodia vacated his office as Non-Executive Non-Independent Director effective July 10, 2026, following the constitution of a new Board of Directors on June 23, 2026, under the approved resolution plan by the NCLT. The company is under Corporate Insolvency Resolution Process (CIRP) since December 22, 2023, with powers of the Board suspended and vested with the Resolution Professional. The resolution plan submitted by Mohini Health & Hygiene Limited was approved by NCLT on April 16, 2026.
- · CIRP initiated on December 22, 2023, by NCLT Chandigarh Bench upon petition by Edelweiss Asset Reconstruction Company Limited under Section 7 of the Insolvency and Bankruptcy Code, 2016.
- · Mr. Sanjay Gupta was appointed as Interim Resolution Professional (IRP) on December 22, 2023.
- · ARCK Resolution Professionals LLP was appointed as Resolution Professional (RP) on March 14, 2024.
- · New Board of Directors constituted effective June 23, 2026, under the approved resolution plan.
- · Monitoring Committee meeting held on July 10, 2026, noted and approved the vacation of office of Mr. Manish Bagrodia.
10-07-2026
Rotographics (India) Limited's board approved a strategic acquisition of up to 51% of Teneron Limited, a non-ferrous metal recycler with FY25 revenue of ₹7080.04 Crore, for cash consideration. The board also approved a 1:5 stock split, an increase in authorized share capital from ₹25 Crore to ₹40 Crore, a name change to Novalum Materials Limited, and material related-party transactions with Teneron up to ₹250 Crore. However, Teneron's revenue declined from ₹798.182 Crore in FY24 to ₹708.004 Crore in FY25, a drop of approximately 11.3%.
- · The board approved a 1:5 stock split (face value from ₹10 to ₹2) to enhance liquidity and widen shareholder base.
- · Authorized share capital to increase from ₹25 Crore to ₹40 Crore.
- · Company name to change to Novalum Materials Limited, subject to shareholder and regulatory approvals.
- · Registered office to shift within Delhi to 138-139, Main Road, Ghazipur, effective July 13, 2026.
- · 51st Annual General Meeting scheduled for August 6, 2026.
- · Mr. Vivek Kumar appointed as Scrutinizer for the AGM.
- · Teneron Limited was incorporated on April 11, 2017, and is an advanced non-ferrous metal recycler.
10-07-2026
UGRO Capital Limited has received observation letters from NSE and BSE conveying no-objection to its proposed scheme of amalgamation with Profectus Capital Private Limited (PCPL), subject to compliance with various conditions. The scheme remains subject to approvals from shareholders, creditors, NCLT, and other regulators. The observation letters include SEBI comments requiring detailed disclosures on ongoing adjudication, recovery proceedings, and enforcement actions against the company, promoters, and directors.
- · NSE observation letter dated July 09, 2026 (ref: NSE/LIST/53237/53236) and BSE letter dated July 10, 2026 (ref: DCS/AMAL/RD/R59A/148/2026-27 & DCS/AMAL/RD/R37/149/2026-27) were received.
- · SEBI comments dated May 22, 2026 and July 08, 2026 were included in the NSE letter, requiring compliance with various conditions including disclosure of ongoing adjudication & recovery proceedings, prosecution initiated, and enforcement actions against the company, promoters, and directors.
- · The validity of the NSE observation letter is six months from July 09, 2026, within which the scheme must be submitted to NCLT.
- · A certificate by Maheshwari & Co., Chartered Accountants dated May 15, 2026, certifying pre and post scheme balances of Capital Reserve and Securities Premium Account was referenced.
- · The company must file a compliance status report on NEAPS portal stating compliance with each point of the observation letter.
10-07-2026
Kitex Garments Limited (KGL) has issued an addendum to the notice of its equity shareholders' meeting scheduled for July 24, 2026, to consider a Scheme of Arrangement with Kitex Childrenswear Limited (KCL). The scheme involves the demerger of KCL's textile manufacturing division (including its 30% stake in Kitex Apparel Parks Limited and 50% stake in Kitex USA LLC) into KGL, with KGL issuing new equity shares to KCL shareholders as consideration. The consolidation aims to create operational efficiencies and unlock value, but the filing provides no financial details on the valuation or the share entitlement ratio, and the scheme is subject to shareholder and regulatory approvals.
- · The meeting of equity shareholders is scheduled for July 24, 2026 at 11:00 AM IST via VC/OAVM.
- · The cut-off date for determining shareholders entitled to receive the addendum is May 29, 2026.
- · KCL has 56 production lines and employs around 4900 employees; KGL has 42 garment manufacturing lines and also employs around 4900 employees.
- · The scheme will result in Kitex Apparel Parks Limited and Kitex USA LLC becoming 100% subsidiaries of KGL.
- · Post-demerger, KCL will retain investments in various subsidiaries, outstanding advances, investment in equity of KGL, and investment in land and building.
- · The addendum was filed in compliance with an NSE observation letter and includes additional information as per Annexure M of the NSE checklist.
10-07-2026
IREDA has declared M/s Gensol Engineering Limited and its subsidiary M/s Gensol EV Lease Limited as fraud accounts, reporting them to the RBI under the Fraud Risk Management Directions for NBFCs. The total outstanding amount across both borrowers is ₹672.74 Crore, with provisions held at 85% as of March 31, 2026. The fraud involves misappropriation, criminal breach of trust, and forgery.
- · The fraud was reported to RBI under the Master Direction – Fraud Risk Management in NBFCs Directions, 2024.
- · Nature of fraud includes misappropriation, criminal breach of trust, and forgery with intention to commit fraud by making false documents and/or electronic records.
- · The disclosure is made under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
10-07-2026
Inventurus Knowledge Solutions Limited disclosed that its wholly-owned subsidiary, IKS Inc., has executed a subordination agreement on July 10, 2026, in connection with the acquisition of TruBridge, Inc. The agreement subordinates intercompany debts (including shareholder loans, dividends, and management fees) to the obligations under financing facilities of up to USD 635,000,000 availed by IKS Inc. This step is a routine financing condition for the acquisition and does not introduce new financial metrics or performance data.
- · The subordination agreement was executed on July 10, 2026, with Axis Trustee Services Ltd. GIFT City Branch as trustee.
- · Intercompany debts subordinated include shareholder loans, dividends, and management fees, but exclude general trade receivables or intra-group receivables arising in the ordinary course on arm's length terms.
- · The disclosure follows prior communications on April 23, July 2, 3, 6, and 9, 2026, regarding the acquisition.
10-07-2026
GeoVax Labs, Inc. (GOVX) received a Nasdaq notice on July 7, 2026, for non-compliance with the $2,500,000 minimum stockholders' equity requirement (Listing Rule 5550(b)(1)) and its alternatives. The company has 45 days (until August 21, 2026) to submit a compliance plan; if accepted, Nasdaq may grant up to 180 additional days to regain compliance. While the stock continues trading under GOVX for now, failure to regain compliance could lead to delisting, and there is no assurance the plan will be accepted or successful.
- · The company also failed to meet the alternative compliance measures: market value of listed securities or net income from continuing operations.
- · If the Staff does not accept the plan or compliance is not achieved within the extension, a delisting determination would be issued, and the company could request a hearing before a Nasdaq Hearings Panel, which would stay any delisting action.
10-07-2026
ENvue Medical, Inc. (formerly NanoVibronix, trading as FEED) received a Nasdaq Staff Determination letter on July 10, 2026, stating that its common stock closing bid price has been below $1.00 for 30 consecutive business days (May 26–July 8, 2026), violating the Minimum Bid Price Requirement (Nasdaq Rule 5550(a)(2)). Because the company effected a 1-for-10 reverse stock split on August 12, 2025, it is not eligible for the standard 180-day compliance period. The company intends to request a hearing to appeal the determination, which will stay any delisting pending the Panel's decision, but there is no assurance of success.
- · The company's common stock trades under the symbol FEED on the Nasdaq Capital Market.
- · The reverse stock split was effected on August 12, 2025.
- · The non-compliance period ran from May 26, 2026 through July 8, 2026.
- · The company intends to request a hearing under the Nasdaq Listing Rule 5800 Series to appeal the Staff Determination.
10-07-2026
Nu-Med Plus, Inc. (NUMD) announced the acquisition of Avid Gold Ltd and its subsidiary Maritimes Gold Corp., and a separate agreement to acquire six gold properties in Atlantic Canada from MegumaGold Corp. The company is diversifying from its medical device business into gold exploration and development. The acquisition of the properties is subject to conditions including MegumaGold shareholder approval, and the company faces risks related to financing, dilution, and the uncertainty of mineral recovery.
- · The acquisition of Avid Gold is completed; the acquisition of the six gold properties from MegumaGold is subject to conditions including MegumaGold shareholder approval.
- · The properties span more than 30,900 acres in Nova Scotia, New Brunswick, and Newfoundland and Labrador, with four located in the Meguma Terrane.
- · Fred Tejada brings over 40 years of international mining experience and will lead gold exploration.
- · The company's shares are quoted on the OTCQB Venture Market.
- · Risks include the need for additional financing, potential dilution from convertible preferred stock, and no assurance that minerals will be recovered economically.
10-07-2026
Lakeside Holding Ltd (LSH) received a second notice from Nasdaq on July 9, 2026, granting an additional 180-day compliance period (until January 4, 2027) to regain the minimum $1.00 bid price requirement. The company had previously failed to meet the bid price rule based on 30 consecutive business days ending January 6, 2026. While the extension provides time to cure, there is no assurance of regaining compliance, and failure could lead to delisting.
- · The initial non-compliance period was from November 14, 2025 to January 6, 2026 (30 consecutive business days).
- · The first compliance period ended July 7, 2026, without regaining compliance.
- · The second compliance period runs until January 4, 2027.
- · To regain compliance, the closing bid price must be at least $1.00 for a minimum of 10 consecutive business days (Nasdaq may require up to 20 days).
- · If a reverse stock split is used, it must be completed no later than 10 business days before January 4, 2027.
- · The company may appeal a delisting determination to a Nasdaq Hearings Panel.
- · The notice has no immediate effect on the listing of LSH common stock on the Nasdaq Capital Market.
10-07-2026
Spring Valley Acquisition Corp. III (SVACW) has been delisted from Nasdaq effective July 10, 2026, pursuant to SEC Rule 17 CFR 240.12d2-2(a)(3). The delisting was initiated by Nasdaq Stock Market LLC, and the company's securities will no longer trade on the exchange.
- · Delisting effective date: July 10, 2026
- · SEC file number: 001-42822
- · Company incorporated in Z4 (Cayman Islands) with business address in Richmond, Canada
- · Rule cited: 17 CFR 240.12d2-2(a)(3) — typically used for involuntary delisting or failure to meet listing standards
10-07-2026
Innovator ETFs Trust received a delisting notice from Nasdaq Stock Market LLC for the Innovator Hedged Nasdaq-100 ETF, filed on July 10, 2026, under SEC Rule 17 CFR 240.12d2-2(a)(2). The delisting is effective as of the same date, indicating the security will be removed from Nasdaq listing.
- · Filing type: 25-NSE (Notice of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934)
- · SEC file number: 333-146827
- · Effectiveness date: July 10, 2026
- · Rule cited: 17 CFR 240.12d2-2(a)(2) (voluntary or involuntary delisting)
- · Trust incorporated in Delaware, fiscal year end October 31
10-07-2026
Skillsoft Corp. completed the sale of its Global Knowledge Training LLC business (instructor-led training) to an affiliate of Enduring Ventures for total consideration of up to approximately $15.4 million. The deal includes an initial consideration of about $5.4 million paid via promissory note, $10.0 million in deferred consideration (minus ~$2.0 million for employee liabilities) payable quarterly starting nine months after closing, plus contingent consideration. Pro forma financials show the continuing operations generated a net loss of $18.5 million (or $2.10 per share) for the three months ended April 30, 2026, and an $84.4 million net loss (or $9.82 per share) for fiscal year ended January 31, 2026.
- · The deferred consideration of $10.0M is reduced by approximately $2.0M related to long-term employee liabilities.
- · The promissory note for the initial consideration is secured by the Company’s cash and accounts receivable.
- · The Buyer’s obligation to pay deferred consideration is guaranteed by the Company and secured by the Transferred Companies’ intellectual property rights.
- · GK business was previously classified as discontinued operations; pro forma adjustments also remove historical operating results for FY2024, FY2025, and FY2026.
- · Transaction accounting adjustments in the pro forma statement of operations for FY2026 include $1.23M of interest income on the promissory note.
- · Pro forma long-term debt remains high at $568.2M as of April 30, 2026.
10-07-2026
Mercer International Inc. received a Nasdaq notice on July 9, 2026, for non-compliance with the $1.00 minimum bid price rule, based on its closing bid price over the last 30 consecutive business days. The company has a 180-day compliance period to regain compliance by achieving a closing bid price of at least $1.00 for ten consecutive business days. While the notice does not currently affect listing or trading, there is no assurance that compliance will be regained, posing a risk of eventual delisting.
- · The notice is a notice of non-compliance, not of imminent delisting, and does not currently affect listing or trading.
- · The company is actively monitoring its stock price and working to regain compliance, but there is no assurance of success.
- · The filing includes forward-looking statements with risks and uncertainties regarding compliance.
10-07-2026
XMax Inc. (XWIN) disclosed that its wholly owned subsidiary, Xmax Beta Holdings Ltd., entered into a Subscription Agreement on July 6, 2026, to make an additional subscription of $8,770,000 in Preamble X Capital I, increasing its interest to over 99.9%. The subscription was completed on July 7, 2026, and the management fee for the Company is 0%. This transaction effectively consolidates the Company's control over the investment vehicle.
- · The subsidiary Xmax Beta Holdings Ltd. is incorporated in the Cayman Islands.
- · Preamble X Capital I is a series of Preamble X Capital LLC, a Delaware LLC.
- · Allocations Fund Administration, LLC serves as the administrative manager of Preamble X Capital I.
- · The filing was made under Items 1.01, 2.01, and 9.01 of Form 8-K.
10-07-2026
Quetta Acquisition Corp deposited $60,000 into its trust account on July 10, 2026, to extend the deadline for completing its initial business combination by one month, from July 10, 2026, to August 10, 2026. This extension indicates the company has not yet consummated a merger and is buying additional time, which may signal challenges in closing a deal.
- · The extension is from July 10, 2026 to August 10, 2026 (one month).
- · The payment was made for the benefit of public stockholders.
- · The company is a SPAC (special purpose acquisition company) with units, common stock, and rights listed on Nasdaq under symbols QETAU, QETA, and QETAR.
10-07-2026
Lincoln Educational Services Corp's subsidiary, Lincoln Technical Institute, Inc., entered into a $15,040,000 loan agreement with Provident Bank on July 7, 2026, to finance the acquisition of a mortgaged property and related closing costs. The loan is secured by the property and guaranteed by the parent company and three acquisition-related LLCs. The filing confirms the loan is permitted under the company's existing Fifth Third credit agreement and does not indicate any adverse financial trends or defaults.
- · The loan is secured by a Mortgage, Assignment of Leases and Rents, and UCC fixture filings on the property.
- · Guarantors include the parent company and three acquisition LLCs: New England Acquisition, LLC, NN Acquisition, LLC, and Nashville Acquisition, L.L.C.
- · The loan is intended to be permitted Indebtedness under the existing Fifth Third Credit Agreement; no conflict or default arises from the existing credit facility.
- · The Borrower paid a $75,200 loan fee at closing.
10-07-2026
Viking Acquisition Corp. II, a blank-check company, completed its initial public offering (IPO) on July 6, 2026, issuing 23,000,000 units at $10.00 per unit for gross proceeds of $230,000,000. Simultaneously, it sold 610,000 private placement units to the sponsor and underwriter for additional gross proceeds of $6,100,000. The net proceeds of $230,000,000 are held in a trust account pending an initial business combination; the company has not yet identified a target and has no operating revenues.
- · The company was incorporated on February 24, 2026, and has not yet commenced operations.
- · The underwriters' over-allotment option of 3,000,000 units was fully exercised.
- · No underwriting discounts or commissions were paid on the private placement units.
- · The trust account funds will be released only upon completion of an initial business combination, certain charter amendments, or failure to complete a business combination within the completion window.
- · The company has an accumulated deficit of $8,325,096 and total shareholders' deficit of $8,324,268 as of July 6, 2026.
- · The company has 200,000,000 Class A ordinary shares authorized, with 610,000 issued and outstanding (excluding 23,000,000 shares subject to possible redemption).
- · The company has 20,000,000 Class B ordinary shares authorized, with 7,666,667 issued and outstanding.
10-07-2026
Plum Acquisition Corp. IV amended its business combination agreement with Controlled Thermal Resources Holdings Inc., reducing the merger valuation from $4.5B to $3.15B and cutting the earnout share pool from 100M to 70M shares. The amendment also extends the outside closing date to April 30, 2027, and increases the maximum non-redemption incentive shares from 2M to 3M. While the revised terms may improve deal feasibility, the significant valuation reduction and extended timeline signal potential challenges in completing the transaction.
- · Antitrust filing deadline extended from July 31, 2026 to September 30, 2026.
- · Outside closing date extended from December 31, 2026 to April 30, 2027.
- · Each of the eight earnout tranches reduced proportionally from 12,500,000 to 8,750,000 shares.
- · Plum IV is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.
- · The business combination involves a merger of Merger Sub with and into Controlled Thermal Resources, with the Company surviving.
10-07-2026
BurTech Acquisition Corp II announced that holders of its units may elect to separately trade the underlying Class A ordinary shares and warrants commencing July 14, 2026. The units were sold in the company's initial public offering completed on May 21, 2026. This is a routine administrative step for a SPAC after its IPO, with no financial results or business combination announced.
- · The units were initially offered in an underwritten IPO that closed on May 21, 2026.
- · D Boral Capital LLC acted as lead book-running manager for the IPO.
- · No fractional warrants will be issued upon separation; only whole warrants will trade.
- · The company is a blank check company focused on acquiring a business in retail, lifestyle, hospitality, technology, or real estate markets.
10-07-2026
Kuva Labs, Inc., through its subsidiary Kuva Acquisition Corp., has extended its tender offer to acquire all outstanding shares of Lisata Therapeutics, Inc. to July 16, 2026. As of July 10, 2026, approximately 5.1 million shares (55.98% of outstanding) had been validly tendered. The offer price is $4.00 per share in cash plus one contingent value right (CVR) worth up to an additional $3.00 per share, subject to milestones. The extension suggests the minimum tender condition may not yet be fully satisfied, though the filing indicates the offer is expected to close promptly after expiration.
- · The tender offer was originally scheduled to expire on July 10, 2026, but has been extended to July 16, 2026.
- · The offer is a third-party tender offer subject to Rule 14d-1.
- · Kuva Labs has entered into a non-binding LOI for up to $25M in senior secured convertible notes at 15% PIK interest to fund the acquisition.
- · Kuva Labs has a SAFE with ER Trust for $3.5M that converts at an 80% discount post-merger.
- · The closing of the note financing is conditioned on Kuva Labs raising a minimum of $20M in new equity.
- · A total of 866,038 rollover shares will be contributed by 16 stockholders, including trusts and individuals.
- · The largest rollover stockholder is Leading Choice with 423,322 shares.
- · The CVR agreement provides for contingent cash payments of up to $3.00 per share upon achievement of milestones.
10-07-2026
Nuvalent, Inc. filed Amendment No. 2 to its Schedule 14D-9, disclosing that the HSR Act waiting period for the tender offer by GSK's subsidiary to acquire all outstanding shares for $124.00 per share expired on July 9, 2026. The offer remains subject to other closing conditions.
- · HSR Act waiting period expired at 11:59 p.m. Eastern Time on July 9, 2026.
- · Premerger Notification and Report Forms were filed on June 24, 2026.
- · Offer and Merger remain subject to other closing conditions.
10-07-2026
GSK plc, through its subsidiaries, is proceeding with a tender offer to acquire all outstanding shares of Nuvalent, Inc. for $124.00 per share in cash. The required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired on July 9, 2026, satisfying the HSR condition to the offer. This amendment (No. 3) updates the tender offer statement to reflect the expiration of the HSR waiting period.
- · The HSR waiting period expired effective July 9, 2026, at 11:59 PM Eastern Time.
- · The tender offer is for all issued and outstanding Class A and Class B common shares of Nuvalent.
- · The offer price is $124.00 per share, net to the seller in cash, without interest.
- · This is Amendment No. 3 to the Schedule TO filed on July 10, 2026.
10-07-2026
T1 Energy Inc. (formerly FREYR Battery) is being delisted from the New York Stock Exchange effective July 21, 2026, after its warrants were suspended from trading on July 9, 2026, because the instruments now represent only the right to receive an immediate cash payment rather than equity. The delisting is a negative event for warrant holders, as the securities have lost their equity conversion feature.
- · The delisting is effective at the opening of business on July 21, 2026.
- · Trading of the warrants was suspended on July 9, 2026.
- · The warrants now represent only the right to receive an immediate cash payment, with no other rights.
- · The company changed its name from FREYR Battery, Inc. on September 1, 2023.
- · The delisting is pursuant to Rule 12d2-2(a)(3) of the Securities Exchange Act of 1934.
10-07-2026
Reviva Pharmaceuticals Holdings, Inc. (RVPH) received a final delisting determination from Nasdaq, effective July 20, 2026. The company failed to meet Nasdaq's Listing Rule 5550(a)(2) bid price requirement, and after multiple appeals and extensions, the Panel ultimately suspended trading on May 14, 2026, with the delisting becoming final on June 26, 2026.
- · Nasdaq initially notified the company of non-compliance on November 11, 2025.
- · A hearing was held on January 8, 2026, with a Decision letter issued January 20, 2026.
- · The company requested and received an extension on April 27, 2026, but failed to meet the new deadline.
- · Trading was suspended on May 14, 2026.
- · The delisting was effective at the opening of trading on July 20, 2026.
10-07-2026
Safe & Green Holdings Corp. (SGBX) is acquiring 100% of Psylinks Neurotech Corp., a neurotechnology and applied intelligence company, through its subsidiary Olenox Industries Inc. (OLOX) for a purchase price of $500,000 in restricted shares of OLOX common stock. The transaction has been unanimously approved by both companies' boards, expanding SGBX's operations beyond its current energy business into neurotechnology, AI, and cognitive performance platforms.
- · The transaction is expected to close on July 10, 2026 or a date mutually agreed by the parties.
- · Psylinks Neurotech Corp. is an Alberta corporation.
- · Olenox Industries Inc. is a Delaware corporation and is a subsidiary of SGBX.
- · Psylinks operates across research, human performance, simulation, defense, industrial, and clinical-adjacent settings.
- · The purchase price is $500,000 payable in restricted shares of OLOX common stock.
10-07-2026
GoHealth, Inc. received a final determination from Nasdaq to delist its Class A Common Stock based on Listing Rules 5101, 5110(b), and IM-5101-1. The company did not appeal the Staff's determination, and trading was suspended on June 16, 2026. The delisting will become effective at the opening of the trading session on July 20, 2026.
- · The delisting determination was based on Listing Rules 5101, 5110(b), and IM-5101-1.
- · The Company was notified of the Staff determination on June 9, 2026.
- · The Company did not appeal the delisting determination.
- · Trading was suspended on June 16, 2026.
- · Delisting effective date: July 20, 2026.
10-07-2026
SUIC Worldwide Holdings Ltd. filed an 8-K on July 10, 2026, reporting entry into a material agreement (Items 1.01, 2.01, 5.01, 5.02, 9.01) and provided audited financial statements as Exhibit 99.1. The filing indicates a completed acquisition or merger, as the company disclosed financial statements of a target entity. No specific financial figures or performance comparisons are available in the provided excerpt.
- · Filing type is 8-K with items 1.01 (Material Agreement), 2.01 (Completion of Acquisition), 5.01 (Changes in Control), 5.02 (Departure/Directors), and 9.01 (Financial Statements).
- · Exhibit 99.1 contains audited financial statements of the acquired entity.
10-07-2026
Inotiv, Inc. received a delisting notice from Nasdaq, effective July 20, 2026, after failing to meet listing requirements. The company did not appeal the determination, and its stock was suspended on June 11, 2026.
- · Delisting effective at the opening of trading on July 20, 2026.
- · Company notified of Staff determination on June 4, 2026.
- · Company did not appeal the delisting determination.
- · Common stock suspended on June 11, 2026.
- · Delisting based on Listing Rules 5101, 5110(b), and IM-5101-1.
10-07-2026
Alchemy Investments Acquisition Corp 1 (ALCYU) received a final delisting determination from Nasdaq on July 10, 2026, effective July 20, 2026, after failing to qualify for listing under Rule IM-5101-2. The company did not appeal the delisting decision, and its securities had already been suspended on May 14, 2026.
- · Delisting effective at the opening of the trading session on July 20, 2026.
- · Nasdaq Staff determination based on Listing Rule IM-5101-2.
- · Company notified of Staff determination on May 7, 2026.
- · Company did not appeal the delisting determination.
- · Company securities were suspended on May 14, 2026.
- · Staff determination to delist became final on May 14, 2026.
10-07-2026
Meridian3 Industrials Acquisition Corp completed its IPO of 20,125,000 units at $10.00 per unit on July 6, 2026, generating gross proceeds of $201,250,000. Simultaneously, it completed a private placement of 5,500,000 warrants to the sponsor and underwriters, raising an additional $5,500,000. The total proceeds of $201,250,000 have been placed in a trust account, positioning the SPAC for a future business combination.
- · Each unit consists of one Class A ordinary share and one-half of one redeemable warrant.
- · Each whole warrant entitles the holder to purchase one Class A ordinary share at $11.50 per share.
- · The trust account includes up to $8,575,000 of the underwriters' deferred commission.
- · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.
10-07-2026
Brandywine Realty Trust completed the disposition of a 206,000 square foot office building and parking garage in Austin, Texas on July 9, 2026 for $151.0 million, generating net proceeds of approximately $146.1 million. The pro forma financial statements show a reduction in total assets from $3.588 billion to $3.618 billion and a pro forma net loss attributable to common shareholders of $50.6 million for Q1 2026 (versus historical loss of $48.9 million) and $148.5 million for FY2025 (versus historical loss of $179.5 million). While the disposition improves the balance sheet with $146.1 million in cash proceeds and a pro forma gain of $38.0 million in FY2025, the removal of the property's revenue and expenses increases the net loss in Q1 2026 by $1.7 million, reflecting the loss of operating income from the asset.
- · Pro forma adjustments eliminate $4.7M in revenue and $3.0M in operating expenses for Q1 2026, and $19.3M in revenue and $12.3M in operating expenses for FY2025.
- · The property contributed $2.6M in contractual base rent, $1.3M in reimbursable tenant costs, $0.7M in parking rent, and $0.1M in straight-line rent adjustments in Q1 2026.
- · For FY2025, the property contributed $10.0M in contractual base rent, $5.9M in reimbursable tenant costs, $2.7M in parking rent, and $0.6M in straight-line rent adjustments.
- · Pro forma basic loss per share for Q1 2026 is $(0.29) vs historical $(0.28); for FY2025 it is $(0.86) vs historical $(1.03).
- · The disposition reduces secured debt, credit facility, term loan, and senior notes balances remain unchanged.
- · Total liabilities decrease by $8.1M on a pro forma basis, primarily from elimination of lease liability and deferred income.
Get daily alerts with 10 investment signals, 10 risk alerts, 9 opportunities and full AI analysis of all 48 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Global High-Priority Regulatory Events
🇺🇸 More from United States
View all →July 10, 2026
US Pre-Market SEC Filings Roundup — July 10, 2026
US Pre-Market SEC Filings Roundup
July 10, 2026
US Earnings Financial Results SEC Filings — July 10, 2026
US Earnings Financial Results SEC Filings
July 10, 2026
US Executive Compensation Proxy SEC Filings — July 10, 2026
US Executive Compensation Proxy SEC Filings
July 10, 2026
US SEC Filings Daily Market Digest — July 10, 2026
US SEC Filings Daily Market Digest